Barchester Healthcare Acquisition, Valuation, Funding & Investors

Barchester Healthcare was acquired by Welltower for $6.6B in October 2025, a 5.4x multiple on $1.2B of revenue.

Barchester Healthcare acquisition price

$6.6B

Acquired by Welltower · Oct 2025

Barchester Healthcare revenue at acquisition

$1.2B

Last twelve months · Oct 2025

Barchester Healthcare revenue multiple at acquisition

5.4x

EV/Revenue · Oct 2025

Key investors in Barchester Healthcare

  • John Magnier
  • Dermot Desmond
  • JP McManus

Barchester Healthcare Overview

About Barchester Healthcare

Barchester Healthcare is a United Kingdom care home operator headquartered in Finsbury Square, London, that provides residential, nursing, dementia and specialist care. Set up in the early 1990s by British entrepreneur Mike Parsons, it ran 223 registered services with 14,543 beds in 2024, mostly in London and the south-east of England, and employed about 17,200 people at the end of 2024. It earns fees mainly from privately paying residents rather than from local authorities. Barchester Healthcare Ltd reported revenue of £871 million and pre-tax profit of £39 million for 2023, up from £767 million of revenue in 2022. The Irish investors JP McManus, John Magnier and Dermot Desmond invested in 1994 and owned it through their vehicle Grove Investments; a 2018 sale process at about £2.5 billion, which came close to a deal with Macquarie, was abandoned. In October 2025 Welltower agreed to buy Barchester's real estate portfolio, held through its property company Limecay, for £5.2 billion, while Barchester's management and operations continue under a long-term partnership.


Founded

1993

HQ

United KingdomLondon

Status

Acquired

Customer focus

B2C

Revenue model

Services

Revenue

$1.2B (Oct 2025)

Valuation

$6.6B (acquired Oct 2025)

Barchester Healthcare Acquisition

Barchester Healthcare was acquired by Welltower for $6.6B on 27 October 2025.

The acquisition price implies a 5.4x revenue multiple on $1.2B of revenue.

Welltower, the US healthcare real estate investment trust, announced in late October 2025 the purchase of a real estate portfolio of Barchester-operated communities in the United Kingdom for £5.2 billion, which the trade press called the world's largest care home transaction. The portfolio comprises 111 communities managed by Barchester under a RIDEA contract, 152 triple-net leased communities and 21 developments that will also be managed under RIDEA once complete; HealthInvestor reported that the deal covers Barchester and its property subsidiary Limecay. Welltower formed an exclusive long-term partnership with Barchester, whose management team stays in place, and the triple-net lease carries 3.5% annual escalators and a coverage-based rent reset every five years. Barchester's owners, the Irish investors JP McManus, John Magnier and Dermot Desmond, first invested in 1994 and had come close to selling the group to Macquarie for £2.5 billion about six years earlier. Barchester employed about 17,200 people, and Limecay's property portfolio had a gross value of £1.91 billion at the end of the previous year.

Barchester Healthcare acquisition details
AcquirerDateTypePriceEV/Revenue
27 Oct 2025Strategic M&A$6.6B5.4x

Sources: sec.gov, caring-times.co.uk, en.wikipedia.org

Barchester Healthcare Funding History

Barchester Healthcare has raised 1 funding round.

Barchester Healthcare funding rounds
DateStageInvestorsDeal Summary
Jun 1994Undisclosed stageDermot Desmond; JP McManus; John MagnierIn 1994, a little over a year after the British entrepreneur Mike Parsons set up Barchester Healthcare, the Irish investors John Magnier, JP McManus and Dermot Desmond invested in the business, according to HealthInvestor; the terms were not disclosed. The three men often invest together, jointly bought the Sandy Lane hotel in Barbados in 1997, and later held Barchester through their investment vehicle Grove Investments. Barchester grew from a single care home that Parsons converted from a Cotswolds farm into one of the largest care home groups in the United Kingdom, with 223 registered services and 14,543 beds by 2024 and revenue of GBP 871 million in 2023. In July 2018 the owners mandated JP Morgan to assess a sale at an asking price of around GBP 2.5 billion, and the group came close to a sale to Macquarie before that process was abandoned. In October 2025 Welltower agreed to buy Barchester's real estate portfolio, held through the property company Limecay, for GBP 5.2 billion, the largest care home transaction on record.

Who has invested in Barchester Healthcare?

3 investors have backed Barchester Healthcare across its funding rounds, including John Magnier, Dermot Desmond and JP McManus.


Barchester Healthcare Investors

Investors in Barchester Healthcare by funding rounds participated
InvestorHQRoundsRoleFirst check
Dermot DesmondIrelandDublin1ParticipantJun 1994

This data is available for Pro users. Sign up to see all 3 Barchester Healthcare investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Barchester Healthcare Competitors

Barchester Healthcare competitors include listed companies like Chemed, Hinge Health, Ensign Group and National Healthcare Corp, and private ones like Luz Saude and Honor.

Public and private companies comparable to Barchester Healthcare
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
ChemedUnited StatesUnited StatesPublicly listed$2.5B$414M$6.8B2.7x
Hinge HealthUnited StatesUnited StatesPublicly listed$588M($522M)$9.3B10.8x
Ensign GroupUnited StatesUnited StatesPublicly listed$5.1B$543M$11B2.2x
National Healthcare CorpUnited StatesUnited StatesPublicly listed$1.5B$204M$3.3B-
Luz SaudePortugalLisbonPrivate-$333M$3.2B-
HonorUnited StatesBoston, MAPrivate--$1.3B-

Barchester Healthcare Public Comps

Barchester Healthcare is no longer listed, but its public comps include Chemed, Hinge Health, National Healthcare Corp, Aveanna Healthcare, Ensign Group, Addus HomeCare, Brookdale Senior Living, Emeis, Extendicare and Attendo.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Chemed$2.5B$414M2.8x2.7x17.4x14.1x
Hinge Health$588M($522M)15.4x10.8x(17.4x)36.3x
National Healthcare Corp$1.5B$204M2.4x-17.5x-
Aveanna Healthcare$2.4B$269M1.8x1.6x16.0x11.9x
Ensign Group$5.1B$543M2.5x2.2x22.9x17.2x
Addus HomeCare$1.4B$155M1.6x1.5x14.7x11.7x
Brookdale Senior Living$3.2B$332M2.3x2.5x22.1x14.8x
Emeis$6.6B$471M1.7x1.6x23.6x10.8x

This data is available for Pro users. Sign up to see all Barchester Healthcare competitors and their valuation data.

Start Free Trial

Common questions about Barchester Healthcare

When was Barchester Healthcare founded?Barchester Healthcare was founded in 1993.
Where is Barchester Healthcare headquartered?Barchester Healthcare is headquartered in London, United Kingdom.
Is Barchester Healthcare publicly listed?No, Barchester Healthcare was acquired by Welltower in October 2025.
Who acquired Barchester Healthcare?Barchester Healthcare was acquired by Welltower in October 2025.
How much was Barchester Healthcare acquired for?Barchester Healthcare was acquired for $6.6B in October 2025, a 5.4x revenue multiple.
What was Barchester Healthcare's last funding round?Barchester Healthcare's last funding round was a undisclosed-stage round in June 1994.
Who are Barchester Healthcare's investors?Barchester Healthcare's investors include Dermot Desmond, JP McManus and John Magnier.
Which companies are comparable to Barchester Healthcare?Companies comparable to Barchester Healthcare include Chemed, Hinge Health, Ensign Group, National Healthcare Corp, Luz Saude and Honor.

See companies similar to Barchester Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial